LITAF 抗体
Quick Overview for LITAF 抗体 (ABIN6989826)
抗原
See all LITAF 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            交叉反应
- 人, 小鼠
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-161 of human LITAF (NP_004853.2).
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        WB 1:300-5000
 IHC-P 1:200-400
 IP(1-2 μg)
 IHC()
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C for 12 months.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - LITAF (Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Factor (LITAF))
- 
                                            别名
- LITAF
- 
                                            背景
- 
                        Synonyms: LITAF,PIG7,SIMPLE,TP53I7 Background: Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. 
- 
                                            基因ID
- 9516
- 
                                            UniProt
- Q99732
- 
                                            途径
- Cellular Response to Molecule of Bacterial Origin
 抗原
- 
                    
 
                                     
                                     
                                    